* Clinical Pharmacology Unit and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, Republic of Korea.
† Department of Pharmacology, School of Medicine, Chonbuk National University, Jeonju, Republic of Korea.
Am J Chin Med. 2016;44(8):1595-1606. doi: 10.1142/S0192415X16500890. Epub 2016 Nov 16.
The total amount of ginsenoside in fermented red ginseng (FRG) is increased by microbial fermentation. The aim of this study was to evaluate whether fermentation time and temperature affect the ginsenoside content during fermentation using an appliance for the preparation of red ginseng. The FRG and fermented red ginseng extracts (FRG-e) were prepared using an appliance for the preparation of red ginseng. The temperature was recorded and time points for sampling were scheduled at pre-fermentation (0[Formula: see text]h) and 18, 36, 48, 60 and 72[Formula: see text]h after the addition of the microbial strains. Samples of FRG and FRG-e were collected to identify changes in the ginsenoside contents at each time point during the fermentation process. The ginsenoside content was analyzed using high performance liquid chromatography (HPLC). The levels of ginsenoside Rh1, Rg3, and compound Y, which are known to have effective pharmacological properties, increased more than three-fold in the final products of FRG relative to samples prior to fermentation. Although the ginsenoside constituents of FRG-e decreased or increased and then decreased during fermentation, the total amount of ginsenoside in FRG-e was even higher than those in FRG; the total amounts of ginsenoside in FRG-e and FRG were 8282.8 and 738.0[Formula: see text]mg, respectively. This study examined the changes in composition of ginsenosides and suggests a method to manufacture high-content total ginsenosides according to the fermentation temperature and process time. Reducing the extraction time is expected to improve the decrease of ginsenosides in FRG-e as a function of the fermentation time.
发酵红参(FRG)中的总皂苷含量通过微生物发酵而增加。本研究旨在使用红参制备装置评估发酵时间和温度对发酵过程中总皂苷含量的影响。使用红参制备装置制备 FRG 和发酵红参提取物(FRG-e)。记录温度,并在发酵前(0[Formula: see text]h)和添加微生物菌株后 18、36、48、60 和 72[Formula: see text]h 时安排采样时间点。在发酵过程的每个时间点收集 FRG 和 FRG-e 的样品,以鉴定总皂苷含量的变化。使用高效液相色谱法(HPLC)分析总皂苷含量。Rh1、Rg3 和化合物 Y 的总皂苷含量已知具有有效的药理特性,在 FRG 的最终产物中比发酵前的样品增加了三倍以上。尽管 FRG-e 的总皂苷成分在发酵过程中减少或增加然后减少,但 FRG-e 中的总皂苷含量甚至高于 FRG;FRG-e 和 FRG 中的总皂苷含量分别为 8282.8 和 738.0[Formula: see text]mg。本研究检查了总皂苷组成的变化,并提出了一种根据发酵温度和过程时间制造高含量总皂苷的方法。预计缩短提取时间可以改善 FRG-e 中总皂苷随发酵时间的减少。